Cidara Therapeutics' CD388 is aimed at providing universal protection with a single yearly dose for each flu season. See why ...

Ireland’s SynOx Therapeutics has completed a second-round financing, raising $75 million, as it prepares to take its drug for tenosynovial giant cell tumour (TGCT) into phase 3 trials.

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings ...

Trump’s Air Force One? Qatar’s $400M jet needs $1B in upgrades. Here are the 10 biggest changes the USAF will have to make.

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck ...

AstraZeneca has announced positive results from the Phase III KALOS and LOGOS clinical trials of Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) in ...

Moderna (MRNA) stock trades flat as the U.S. cancels a $766M contract granted for the company to develop a vaccine against ...

Today, central and southern areas will see showery rain in the morning clearing to variable cloud and a few blustery showers later. In the north, the day will be quite cloudy with scattered ...